TDP-43 pathology in the population: Prevalence and associations with dementia and age

Journal of Alzheimer's Disease

Volumn 42, Issue 2, 2014, Pages 641-650

  Keage, Hannah A D ^a   Hunter, Sally ^b   Matthews, Fiona E ^c   Ince, Paul G ^d   Hodges, John ^e   Hokkanen, Suvi R K ^b   Highley, J Robin ^d   Dening, Tom ^f   Brayne, Carol ^b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MRC BIOSTATISTICS UNIT   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f INSTITUTE OF MENTAL HEALTH   (United Kingdom)

Author keywords

Aging; aging; Alzheimer's disease; dementia; population; TDP 43

Indexed keywords

DNA BINDING PROTEIN; PROTEIN TDP-43;

AGED; AGING; ARTICLE; BRAIN TISSUE; DEATH; DEMENTIA; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; ENTORHINAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MINI MENTAL STATE EXAMINATION; NEUROPATHOLOGY; PREVALENCE; TDP 43 PROTEINOPATHY; TEMPORAL CORTEX; BRAIN; COHORT ANALYSIS; FEMALE; HEALTH CARE PLANNING; MALE; METABOLISM; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PSYCHOLOGICAL RATING SCALE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; BRAIN; COHORT STUDIES; COMMUNITY HEALTH PLANNING; DEMENTIA; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES;

EID: 84915754902     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-132351     Document Type: Article

References (34)

1. Neumann M, SampathuDM,Kwong LK,TruaxAC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133.
2. Grossman M, Wood EM, Moore P, Neumann M, Kwong L, Forman MS, Clark CM, McCluskey LF, Miller BL, Lee VM, Trojanowski JQ (2007) TDP-43 pathologic lesions and clinical phenotype in frontotemporal lobar degeneration with ubiquitin-positive inclusions. Arch Neurol 64, 1449-1454.
3. Lin W-L, Dickson D (2008) Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases. Acta Neuropathol 116, 205-213.
4. LinW-L, Castanedes-CaseyM, DicksonDW(2009) Transactivation responseDNA-binding protein 43 microvasculopathy in frontotemporal degeneration and familial Lewy body disease. J Neuropathol Exp Neurol 68, 1167-1176.
5. Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 61, 435-445.
6. Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, Grossman M, Miller BL, Kretzschmar HA, Lee VM-Y, Trojanowski JQ, Neumann M (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 67, 555-564.
7. Kadokura A,YamazakiT, Lemere CA,Takatama M, Okamoto K (2009) Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: Their relation toADcommon pathology. Neuropathology 29, 566-573.
8. Josephs KA, Whitwell JL, Knopman DS, Hu WT, Stroh DA, Baker M, Rademakers R, Boeve BF, Parisi JE, Smith GE, Ivnik RJ, Petersen RC, Jack CR Jr, Dickson DW (2008) Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology 70, 1850-1857.
9. Higashi S, Iseki E, Yamamoto R, Minegishi M, Hino H, Fujisawa K, Togo T, Katsuse O, Uchikado H, Furukawa Y, Kosaka K, Arai H (2007) Concurrence of TDP-43, tau and synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res 1184, 284-294.
10. Davidson Y, Raby S, Foulds P, Robinson A, Thompson J, Sikkink S,Yusuf I,AminH, DuPlessis D,Troakes C, Al-Sarraj S, Sloan C, Esiri M, Prasher V, Allsop D, Neary D, Pickering- Brown S, Snowden J, Mann DA (2011) TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's Syndrome: Association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol 122, 703-713.
11. Wilson RS1, Yu L, Trojanowski JQ, Chen EY, Boyle PA, Bennett DA, Schneider JA (2013) TDp-43 pathology, cognitive decline, and dementia in old age. JAMA Neurol 70, 1418-1424.
12. Amador-Ortiz C, Ahmed Z, Zehr C, Dickson DW (2007) Hippocampal sclerosis dementia differs from hippocampal sclerosis in frontal lobe degeneration. Acta Neuropathol 113, 245-252.
13. Josephs K, Murray M, Whitwell J, Parisi J, Petrucelli L, Jack C, Petersen R, Dickson D (2014) Staging TDP-43 pathology in Alzheimer's disease. Acta Neuropathol 127, 441-450.
14. Nelson PT, Schmitt FA, Lin Y, Abner EL, Jicha GA, Patel E, Thomason PC, Neltner JH, Smith CD, Santacruz KS, Sonnen JA, Poon LW, Gearing M, Green RC, Woodard JL, Van Eldik LJ, Kryscio RJ (2011) Hippocampal sclerosis in advanced age: Clinical and pathological features. Brain 134, 1506-1518.
15. Kovacs G, Milenkovic I, Wöhrer A, Höftberger R, Gelpi E, Haberler C, Hönigschnabl S, Reiner-Concin A, Heinzl H, Jungwirth S, Krampla W, Fischer P, Budka H (2013) Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: A community-based autopsy series. Acta Neuropathol 126, 365-384.
16. HuW, Josephs K, Knopman D, Boeve B, Dickson D, Petersen R, Parisi J (2008) Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease. Acta Neuropathol 116, 215-220.
17. Nelson PT, Abner EL, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD, Davis DG, Poduska JW, Patel E, Mendiondo MS, MarkesberyWR(2010) Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol 20, 66-79.
18. Nakashima-Yasuda H, Uryu K, Robinson J, Xie SX, Hurtig H, Duda JE, Arnold SE, Siderowf A, Grossman M, Leverenz JB, Woltjer R, Lopez OL, Hamilton R, Tsuang DW, Galasko D, Masliah E, Kaye J, Clark CM, Montine TJ, Lee VM, Trojanowski JQ (2007) Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol 114, 221-229.
19. Wilson A, Dugger BN, Dickson DW,Wang D-S (2011) TDP- 43 in aging and Alzheimer's disease - a review. Int J Clin Exp Pathol 4, 147-155.
20. Geser F, Robinson JL, Malunda JA, Xie SX, Clark CM, Kwong LK, Moberg PJ, Moore EM, Van Deerlin VM, Lee VM-Y, Arnold SE, Trojanowski JQ (2010) Pathological 43- kDa transactivation response DNA-binding protein in older adults with and without severe mental illness. Arch Neurol 67, 1238-1250.
21. Hasegawa M, Arai T, Akiyama H, Nonaka T, Mori H, Hashimoto T, Yamazaki M, Oyanagi K (2007) TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain 130, 1386-1394.
22. Arnold S, Dugger B, Beach T (2013) TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: Correlation with argyrophilic grains but not other concomitant pathologies. Acta Neuropathol 26, 51-57.
23. Yarchoan M, Xie SX, Kling MA, Toledo JB, Wolk DA, Lee EB, Van Deerlin V, Lee VM-Y, Trojanowski JQ, Arnold SE (2012) Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. Brain 135, 3749-3756.
24. Robinson JL, Geser F, Corrada MM, Berlau DJ, Arnold SE, Lee VM-Y, Kawas CH, Trojanowski JQ (2011) Neocortical and hippocampal amyloid- and tau measures associate with dementia in the oldest-old. Brain 134, 3708-3715.
25. Fleming J, Zhao E, O'Connor DW, Pollitt PA, Brayne C (2007) Cohort profile: The Cambridge City over-75 s Cohort (CC75C). Int J Epidemiol 36, 40-46.
26. Brayne C, Richardson K, Matthews F, Fleming J, Hunter S, Xuereb H, Huppert F, O'Sullivan A, Paykel E, Dening T, CCsn collaboration (2009) Neuropathological correlates of dementia in over-80-year-old brain donors from the population-based Cambridge City over-75 s Cohort (CC75C) study. J Alzheimers Dis 18, 1875-8908.
27. Richardson K, Hunter S, Dening T, Xuereb JH, Matthews FE, Brayne C, Fleming J, Cambridge City over-75 s Cohort Study NeuropathologyC(2012) Neuropathological correlates of falling in the CC75C population-based sample of the older old. Curr Alzheimer Res 9, 697-708.
28. APA (1987) Diagnostic and Statistical Manual of Mental Disorders. DSM-III-R. American Psychiatric Association, Washington, DC.
29. Mirra SS, Heyman A,McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-486.
30. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259.
31. Foulds P, McAuley E, Gibbons L, Davidson Y, Pickering- Brown SM, Neary D, Snowden JS, Allsop D, Mann DM (2008) TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration. Acta Neuropathol 116, 141-146.
32. Keage HA, Ince PG, Matthews FE, Wharton SB, McKeith IG, Brayne C (2012) Impact of less common and"disregarded" neurodegenerative pathologies on dementia burden in a population-based cohort. J Alzheimers Dis 28, 485-493.
33. Matthews FE, Brayne C, Lowe J, McKeith I, Wharton SB, Ince P (2009) Epidemiological pathology of dementia: Attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Med 6, e1000180.
34. Bussière T, Friend PD, Sadeghi N,Wicinski B, Lin GI, Bouras C, Giannakopoulos P, Robakis NK, Morrison JH, PerlDP, Hof PR (2002) Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's disease. Neuroscience 112, 75-91.